FDA rejects psychedelic drug MDMA as a treatment for PTSD
FDA declined to approve MDMA for PTSD therapy, setback for psychedelic drugs in mental health
Veterans and Lawmakers Lobby in Bipartisan Push for MDMA Therapy
The FDA is nearing a decision on using MDMA for PTSD treatment, with lobbying for approval due to the potential positive impact on mental health, particularly for veterans.
FDA panel votes against ecstasy for PTSD
The FDA usually follows advisory committees' advice, with a decision expected on Lykos Therapeutics' drug application by Aug. 11.
FDA rejects psychedelic drug MDMA as a treatment for PTSD
FDA declined to approve MDMA for PTSD therapy, setback for psychedelic drugs in mental health
Veterans and Lawmakers Lobby in Bipartisan Push for MDMA Therapy
The FDA is nearing a decision on using MDMA for PTSD treatment, with lobbying for approval due to the potential positive impact on mental health, particularly for veterans.
FDA panel votes against ecstasy for PTSD
The FDA usually follows advisory committees' advice, with a decision expected on Lykos Therapeutics' drug application by Aug. 11.